Other key patents IBM obtained last year were for predicting traffic problems by using GPS and communicating the delays to drives, finding patterns across disparate data sources and an invention for enabling analysis of medical data from multiple sources to improve the research, diagnosis and treatment of medical conditions.

FORBES: IBM's 20th Year Of Record U.S. Patents Leads With Cognitive Computing

From medical imaging to structural analysis applications, data integrity and precision is assured, without sacrificing performance.

ENGADGET: NVIDIA debuts new slew of Quadro mobile GPUs, each sporting Optimus for battery life too

The results, published in the prestigious Journal of the American Medical Association, are not new but a re-analysis of the data that was used to get the medicine, Natrecor, approved by the U.S. Food and Drug Administration.

FORBES: Magazine Article

Following a positive interim analysis showing that fractional flow-reserve-guided PCI was superior to optimal medical treatment, an independent Data and Safety Monitoring Board (DSMB) has recommended that patient enrollment in the ongoing FAME II trial be stopped.

FORBES: New Enrollment in FAME II Halted After Interim Analysis Shows Benefits of FFR